Ocuphire Pharma Total Assets 2010-2024 | IRD
Ocuphire Pharma total assets from 2010 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
Ocuphire Pharma Annual Total Assets (Millions of US $) |
2023 |
$54 |
2022 |
$49 |
2021 |
$26 |
2020 |
$18 |
2019 |
$2 |
2018 |
$16 |
2017 |
$28 |
2016 |
$21 |
2015 |
$25 |
2014 |
$34 |
2013 |
$20 |
2012 |
$15 |
2011 |
$14 |
2010 |
$16 |
2009 |
$10 |
Ocuphire Pharma Quarterly Total Assets (Millions of US $) |
2024-06-30 |
$45 |
2024-03-31 |
$52 |
2023-12-31 |
$54 |
2023-09-30 |
$54 |
2023-06-30 |
$43 |
2023-03-31 |
$45 |
2022-12-31 |
$49 |
2022-09-30 |
$15 |
2022-06-30 |
$18 |
2022-03-31 |
$20 |
2021-12-31 |
$26 |
2021-09-30 |
$23 |
2021-06-30 |
$25 |
2021-03-31 |
$12 |
2020-12-31 |
$18 |
2020-09-30 |
$9 |
2020-06-30 |
$10 |
2020-03-31 |
$12 |
2019-12-31 |
$2 |
2019-09-30 |
$15 |
2019-06-30 |
$18 |
2019-03-31 |
$19 |
2018-12-31 |
$16 |
2018-09-30 |
$14 |
2018-06-30 |
$18 |
2018-03-31 |
$23 |
2017-12-31 |
$28 |
2017-09-30 |
$25 |
2017-06-30 |
$28 |
2017-03-31 |
$20 |
2016-12-31 |
$21 |
2016-09-30 |
$23 |
2016-06-30 |
$21 |
2016-03-31 |
$26 |
2015-12-31 |
$25 |
2015-09-30 |
$23 |
2015-06-30 |
$27 |
2015-03-31 |
$30 |
2014-12-31 |
$34 |
2014-09-30 |
$36 |
2014-06-30 |
$39 |
2014-03-31 |
$41 |
2013-12-31 |
$20 |
2013-09-30 |
$16 |
2013-06-30 |
$11 |
2013-03-31 |
$13 |
2012-12-31 |
$15 |
2012-09-30 |
$8 |
2012-06-30 |
$10 |
2012-03-31 |
$12 |
2011-12-31 |
$14 |
2011-09-30 |
$19 |
2011-06-30 |
$22 |
2011-03-31 |
$27 |
2010-12-31 |
$16 |
2010-09-30 |
$18 |
2010-06-30 |
$20 |
2010-03-31 |
$10 |
2009-12-31 |
$10 |
2009-09-30 |
$7 |
2009-06-30 |
$5 |
2009-03-31 |
$3 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.031B |
$0.019B |
Ocuphire Pharma Inc. is a clinical-stage ophthalmic biopharmaceutical company. It is focused on developing and commercializing therapies for the treatment of several eye disorders. The company's product pipeline includes Nyxol Eye Drops(R) and APX3330. Ocuphire Pharma Inc., formerly known as Rexahn Pharmaceuticals Inc., is based in FARMINGTON HILLS, Mich.
|